These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29888876)

  • 1. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
    Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
    Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
    Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
    Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
    Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
    Mita Y; Aoyagi Y; Suda T; Asakura H
    J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
    Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
    Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
    Naitoh A; Aoyagi Y; Asakura H
    J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
    Comunale MA; Wang M; Rodemich-Betesh L; Hafner J; Lamontagne A; Klein A; Marrero J; Di Bisceglie AM; Gish R; Block T; Mehta A
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1222-9. PubMed ID: 21467232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute Quantification of
    Kim KH; Lee SY; Kim DG; Lee SY; Kim JY; Yoo JS
    Anal Chem; 2020 Sep; 92(18):12588-12595. PubMed ID: 32786443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
    Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
    Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma.
    Wu M; Liu Z; Zhang A; Li N
    Int J Biol Markers; 2019 Mar; 34(1):20-26. PubMed ID: 30854929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
    Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
    J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
    Shu H; Li W; Shang S; Qin X; Zhang S; Liu Y
    Discov Med; 2017 Mar; 23(126):163-168. PubMed ID: 28472609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
    Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
    Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.
    Moriya S; Morimoto M; Numata K; Nozaki A; Shimoyama Y; Kondo M; Nakano M; Maeda S; Tanaka K
    Anticancer Res; 2013 Mar; 33(3):997-1001. PubMed ID: 23482772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.
    Dela Rosa MA; Chen WC; Chen YJ; Obena RP; Chang CH; Capangpangan RY; Su TH; Chen CL; Chen PJ; Chen YJ
    Anal Chem; 2017 Apr; 89(7):3973-3980. PubMed ID: 28323416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
    Tanabe K; Kitagawa K; Kojima N; Iijima S
    J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.